5 days ago
KYTX
AnalystsDerek ArchilaDerek Archila's Stock Forecasts
AnalystsDerek Archila
Analyst Ranking
Top 3%
#107 out of 5157 analysts
Average Return
+26.72%
Win Rate
60%96 out of 160
Risk vs Reward
Poor
Good
Derek Archila's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +1,563.62% | $0.87 | $14.54 | 2022-09-14 - 2023-09-13 | Strong Buy |
Prometheus Biosciences IncRXDX | +604.58% | $27.52 | $193.90 | 2022-05-13 - 2023-05-12 | Strong Buy |
Prometheus Biosciences IncRXDX | +294.01% | $50.74 | $199.92 | 2022-08-29 - 2023-06-15 | Strong Buy |
Anaptysbio IncANAB | +204.79% | $15.02 | $45.78 | 2024-12-12 - 2025-12-11 | Strong Buy |
Alumis IncALMS | +190.98% | $3.88 | $11.29 | 2025-07-25 - 2025-12-19 | Strong Buy |
Derek Archila Analyst Color
Get additional color on Derek Archila's coverage of popular stocks
5 days ago
GLUE
12 days ago
KYMR
13 days ago
ORIC
13 days ago
INCY
a month ago
ANNX
a month ago
SEPN
a month ago
BBIO
2 months ago
KYTX
2 months ago
INCY
2 months ago
KYTX
3 months ago
CCCC
4 months ago
ASND
5 months ago
ARGX
5 months ago
RYTM
6 months ago
ATYR
8 months ago
RYTM
10 months ago
ARGX
a year ago
ARGX
a year ago
CCCC
a year ago
KYMR
a year ago
ARGX
a year ago
SLRN
a year ago
ASND
a year ago
ARGX
Derek Archila's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Argenx SeARGX | 14 | Strong Buy | $1,264.00 | +47.84% | Maintains | 5 days ago |
Nurix Therapeutics IncNRIX | 7 | Strong Buy | $30.00 | +61.99% | Maintains | 5 days ago |
Kyverna Therapeutics IncKYTX | 4 | Strong Buy | $33.00 | +358.97% | Maintains | 5 days ago |
Disc Medicine IncIRON | 1 | Strong Buy | $109.00 | +36.18% | Maintains | 5 days ago |
Monte Rosa Therapeutics IncGLUE | 7 | Strong Buy | $22.00 | +41.57% | Upgrades | 5 days ago |
Kymera Therapeutics IncKYMR | 10 | Strong Buy | $116.00 | +38.11% | Maintains | 12 days ago |
Oric Pharmaceuticals IncORIC | 2 | Strong Buy | $25.00 | +210.95% | Maintains | 13 days ago |
Incyte CorpINCY | 11 | Strong Buy | $116.00 | +12.96% | Maintains | 13 days ago |
Annexon IncANNX | 4 | Strong Buy | $27.00 | +422.24% | Maintains | a month ago |
Septerna IncSEPN | 5 | Strong Buy | $28.00 | -5.34% | Upgrades | a month ago |
Bridgebio Pharma IncBBIO | 1 | Strong Buy | $84.00 | +10.09% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | $479.00 | +19.68% | Maintains | a month ago |
Ventyx Biosciences IncVTYX | 5 | Strong Buy | $14.00 | +60.18% | Maintains | a month ago |
Arvinas IncARVN | 8 | Strong Buy | $15.00 | +28.42% | Maintains | a month ago |
Soleno Therapeutics IncSLNO | 2 | Strong Buy | $106.00 | +121.53% | Maintains | 2 months ago |
Anaptysbio IncANAB | 4 | Strong Buy | $81.00 | +65.04% | Maintains | 2 months ago |
Exelixis IncEXEL | 4 | Hold | $30.00 | -32.28% | Maintains | 2 months ago |
Kezar Life Sciences IncKZR | 11 | Hold | $5.00 | -21.14% | Maintains | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 12 | Strong Buy | $32.00 | +29.82% | Upgrades | 2 months ago |
C4 Therapeutics IncCCCC | 6 | Strong Buy | $10.00 | +392.61% | Maintains | 3 months ago |
Atyr Pharma IncATYR | 3 | Hold | $1.00 | +33.33% | Downgrades | 3 months ago |
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $38.00 | +48.44% | Maintains | 4 months ago |
Sutro Biopharma IncSTRO | 1 | Hold | $30.00 | +200.60% | Maintains | 4 months ago |
Cabaletta Bio IncCABA | 11 | Hold | $2.00 | -16.32% | Maintains | 4 months ago |
Ascendis Pharma AASND | 13 | Strong Buy | $295.00 | +47.51% | Maintains | 4 months ago |
Zentalis Pharmaceuticals IncZNTL | 5 | Hold | $5.00 | +257.14% | Maintains | 4 months ago |
Viridian Therapeutics IncVRDN | 2 | Hold | $26.00 | -18.55% | Maintains | 4 months ago |
Alumis IncALMS | 1 | Strong Buy | $17.00 | +50.58% | Initiates Coverage On | 5 months ago |
Rhythm Pharmaceuticals IncRYTM | 6 | Strong Buy | $129.00 | +15.03% | Maintains | 5 months ago |
Blueprint Medicines CorpBPMC | 8 | Hold | $129.00 | -0.36% | Downgrades | 6 months ago |
Q32 Bio IncQTTB | 2 | Hold | $15.00 | +406.76% | Maintains | 9 months ago |
Zymeworks IncZYME | 5 | Hold | $14.00 | N/A | Maintains | a year ago |
Immunovant IncIMVT | 9 | Strong Buy | $45.00 | N/A | Maintains | a year ago |
Acelyrin IncSLRN | 5 | Strong Buy | $13.00 | N/A | Maintains | a year ago |
Morphosys AgMOR | 4 | Hold | $18.25 | N/A | Downgrades | 2 years ago |
Dice Therapeutics IncDICE | 2 | Hold | $48.00 | N/A | Maintains | 3 years ago |
Morphic Holding IncMORF | 5 | Strong Buy | $80.00 | N/A | Maintains | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Hold | $116.50 | N/A | Downgrades | 3 years ago |
Prometheus Biosciences IncRXDX | 4 | Strong Buy | $71.00 | N/A | Maintains | 3 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $71.00 | N/A | Initiates Coverage On | 4 years ago |
Esperion Therapeutics IncESPR | 1 | Hold | $20.00 | N/A | Downgrades | 5 years ago |
Lumos Pharma IncLUMO | 1 | Strong Buy | $24.00 | N/A | Upgrades | 5 years ago |
Momenta Pharmaceuticals IncMNTA | 2 | Hold | $52.50 | N/A | Downgrades | 5 years ago |
Principia Biopharma IncPRNB | 1 | Hold | $100.00 | N/A | Downgrades | 5 years ago |
Inventiva SaIVA | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 5 years ago |
Genfit SaGNFTY | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Galapagos NvGLPG | 1 | Hold | $193.00 | N/A | Downgrades | 5 years ago |
Viela Bio IncVIE | 1 | Hold | $58.00 | N/A | Initiates Coverage On | 6 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $8.00 | N/A | Upgrades | 6 years ago |
Oneok IncOKE | 1 | Strong Buy | $41.00 | N/A | Reiterates | 6 years ago |
Amarin Corp PLCAMRN | 3 | Hold | $160.00 | N/A | Maintains | 6 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $32.00 | N/A | Maintains | 6 years ago |
Dbv Technologies SaDBVT | 3 | Hold | $60.00 | N/A | Downgrades | 6 years ago |
Vanda Pharmaceuticals IncVNDA | 4 | Hold | $29.00 | N/A | Downgrades | 7 years ago |
Heron Therapeutics IncHRTX | 2 | Buy | $50.00 | N/A | Maintains | 7 years ago |
Urogen Pharma LtdURGN | 1 | Buy | $51.00 | N/A | Maintains | 8 years ago |
Perrigo Co PLCPRGO | 1 | Buy | $88.00 | N/A | Initiates Coverage On | 8 years ago |
Pacira Biosciences IncPCRX | 1 | Hold | N/A | N/A | Initiates Coverage On | 8 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.